Spinal Muscle Atrophy (SMA) is a genetic neuromuscular disease. It’s the number 1 genetic cause of infant death and as many as 1in 10,000 live births may be affected. SMA can affect people of any race or gender and survivors require lifelong care and support. About 68% of children with SMA type 1 will die before their 2nd birthday and 82% die after their 4th however survival in these infants is improving with improvements in Respiratory and Nutritional care.
Respiratory muscle weakness is a significant problem for children with SMA. Respiratory care interventions such as caregiver education, Non-Invasive Respiratory Management and Negative Pressure Ventilation are essential to the survival and comfort of children with SMA.
To learn more about SMA and how Respiratory Therapy benefits these patients visit this link.Click Here For PDF